Search research articles
Contact Us
Filters
Showing results (381-390 of 392) with videos related to
Page
of 40
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes
C Loveday, A Garrett, P Law, et al.
Journal of Medical Genetics
|
July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
A C Antoniou, P D P Pharoah, S Narod, et al.
Magnetic Resonance Imaging
|
October 12, 2000
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group
J Brown, D Buckley, A Coulthard, et al.
American Journal of Human Genetics
|
April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
A Antoniou, P D P Pharoah, S Narod, et al.
British Journal of Cancer
|
March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
A C Antoniou, A P Cunningham, J Peto, et al.
Human Molecular Genetics
|
February 13, 2001
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH
C E Bruder, C Hirvelä, I Tapia-Paez, et al.
British Journal of Cancer
|
August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
O M Sinilnikova, A C Antoniou, J Simard, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
BJU International
|
September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
Anita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2021
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
Toni T Seppälä, Mev Dominguez-Valentin, Emma J Crosbie, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 392) with videos related to
Sort By:
Page
of 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes
C Loveday, A Garrett, P Law, et al.
Journal of Medical Genetics
|
July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
A C Antoniou, P D P Pharoah, S Narod, et al.
Magnetic Resonance Imaging
|
October 12, 2000
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group
J Brown, D Buckley, A Coulthard, et al.
American Journal of Human Genetics
|
April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
A Antoniou, P D P Pharoah, S Narod, et al.
British Journal of Cancer
|
March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
A C Antoniou, A P Cunningham, J Peto, et al.
Human Molecular Genetics
|
February 13, 2001
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH
C E Bruder, C Hirvelä, I Tapia-Paez, et al.
British Journal of Cancer
|
August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
O M Sinilnikova, A C Antoniou, J Simard, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
BJU International
|
September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
Anita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2021
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
Toni T Seppälä, Mev Dominguez-Valentin, Emma J Crosbie, et al.
Page
of 40